Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
99 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report focuses on the global Combination Antibody Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Combination Antibody Therapy development in United States, Europe and China.
Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination antibody drugs are actively focusing on developing superior drugs that will deliver standout results. Factors such as encouraging government policies, growing concerns over higher cancer prevalence worldwide, and increasing research and development activities coupled with heavier investments are expected to boost the overall market growth in the near future. Likewise, healthy R&D pipelines are leading towards higher product offerings and also propelling the growth of global�combination antibody therapy market�to a significant extent.
The first and foremost reason for fueling the growth of the chemotherapy/antibody segment is the rise in the rates of cancer across the globe. Cancer is the second leading cause of death globally after cardiovascular disease. The proportion of deaths around the world due to cancer has increased remarkably in the last few years.
In 2017, the global Combination Antibody Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Biogen
Roche Holdings
Seattle Genetics
Amgen
Bristol-Myers Squibb
Eli Lilly
Novartis
Sanofi�
Celgene
Genmab
Market segment by Type, the product can be split into
Chemotherapy/Antibody
Antibody/Antibody
Conjugated Antibodies
Bispecific Antibodies
Market segment by Application, split into
Hospitals
Cancer Research Institutes
Clinics
ASCs
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Combination Antibody Therapy status, future forecast, growth opportunity, key market and key players.
To present the Combination Antibody Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Combination Antibody Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Combination Antibody Therapy Market Size Growth Rate by Type (2013-2025)
1.4.2 Chemotherapy/Antibody
1.4.3 Antibody/Antibody
1.4.4 Conjugated Antibodies
1.4.5 Bispecific Antibodies
1.5 Market by Application
1.5.1 Global Combination Antibody Therapy Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Cancer Research Institutes
1.5.4 Clinics
1.5.5 ASCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Combination Antibody Therapy Market Size
2.2 Combination Antibody Therapy Growth Trends by Regions
2.2.1 Combination Antibody Therapy Market Size by Regions (2013-2025)
2.2.2 Combination Antibody Therapy Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Combination Antibody Therapy Market Size by Manufacturers
3.1.1 Global Combination Antibody Therapy Revenue by Manufacturers (2013-2018)
3.1.2 Global Combination Antibody Therapy Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Combination Antibody Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Combination Antibody Therapy Key Players Head office and Area Served
3.3 Key Players Combination Antibody Therapy Product/Solution/Service
3.4 Date of Enter into Combination Antibody Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Combination Antibody Therapy Market Size by Type (2013-2018)
4.2 Global Combination Antibody Therapy Market Size by Application (2013-2018)
5 United States
5.1 United States Combination Antibody Therapy Market Size (2013-2018)
5.2 Combination Antibody Therapy Key Players in United States
5.3 United States Combination Antibody Therapy Market Size by Type
5.4 United States Combination Antibody Therapy Market Size by Application
6 Europe
6.1 Europe Combination Antibody Therapy Market Size (2013-2018)
6.2 Combination Antibody Therapy Key Players in Europe
6.3 Europe Combination Antibody Therapy Market Size by Type
6.4 Europe Combination Antibody Therapy Market Size by Application
7 China
7.1 China Combination Antibody Therapy Market Size (2013-2018)
7.2 Combination Antibody Therapy Key Players in China
7.3 China Combination Antibody Therapy Market Size by Type
7.4 China Combination Antibody Therapy Market Size by Application
8 Japan
8.1 Japan Combination Antibody Therapy Market Size (2013-2018)
8.2 Combination Antibody Therapy Key Players in Japan
8.3 Japan Combination Antibody Therapy Market Size by Type
8.4 Japan Combination Antibody Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Combination Antibody Therapy Market Size (2013-2018)
9.2 Combination Antibody Therapy Key Players in Southeast Asia
9.3 Southeast Asia Combination Antibody Therapy Market Size by Type
9.4 Southeast Asia Combination Antibody Therapy Market Size by Application
10 India
10.1 India Combination Antibody Therapy Market Size (2013-2018)
10.2 Combination Antibody Therapy Key Players in India
10.3 India Combination Antibody Therapy Market Size by Type
10.4 India Combination Antibody Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Combination Antibody Therapy Market Size (2013-2018)
11.2 Combination Antibody Therapy Key Players in Central & South America
11.3 Central & South America Combination Antibody Therapy Market Size by Type
11.4 Central & South America Combination Antibody Therapy Market Size by Application
12 International Players Profiles
12.1 Biogen
12.1.1 Biogen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Combination Antibody Therapy Introduction
12.1.4 Biogen Revenue in Combination Antibody Therapy Business (2013-2018)
12.1.5 Biogen Recent Development
12.2 Roche Holdings
12.2.1 Roche Holdings Company Details
12.2.2 Company Description and Business Overview
12.2.3 Combination Antibody Therapy Introduction
12.2.4 Roche Holdings Revenue in Combination Antibody Therapy Business (2013-2018)
12.2.5 Roche Holdings Recent Development
12.3 Seattle Genetics
12.3.1 Seattle Genetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Combination Antibody Therapy Introduction
12.3.4 Seattle Genetics Revenue in Combination Antibody Therapy Business (2013-2018)
12.3.5 Seattle Genetics Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Combination Antibody Therapy Introduction
12.4.4 Amgen Revenue in Combination Antibody Therapy Business (2013-2018)
12.4.5 Amgen Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Combination Antibody Therapy Introduction
12.5.4 Bristol-Myers Squibb Revenue in Combination Antibody Therapy Business (2013-2018)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Company Details
12.6.2 Company Description and Business Overview
12.6.3 Combination Antibody Therapy Introduction
12.6.4 Eli Lilly Revenue in Combination Antibody Therapy Business (2013-2018)
12.6.5 Eli Lilly Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Combination Antibody Therapy Introduction
12.7.4 Novartis Revenue in Combination Antibody Therapy Business (2013-2018)
12.7.5 Novartis Recent Development
12.8 Sanofi�
12.8.1 Sanofi� Company Details
12.8.2 Company Description and Business Overview
12.8.3 Combination Antibody Therapy Introduction
12.8.4 Sanofi� Revenue in Combination Antibody Therapy Business (2013-2018)
12.8.5 Sanofi� Recent Development
12.9 Celgene
12.9.1 Celgene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Combination Antibody Therapy Introduction
12.9.4 Celgene Revenue in Combination Antibody Therapy Business (2013-2018)
12.9.5 Celgene Recent Development
12.10 Genmab
12.10.1 Genmab Company Details
12.10.2 Company Description and Business Overview
12.10.3 Combination Antibody Therapy Introduction
12.10.4 Genmab Revenue in Combination Antibody Therapy Business (2013-2018)
12.10.5 Genmab Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Combination Antibody Therapy Key Market Segments
Table Key Players Combination Antibody Therapy Covered
Table Global Combination Antibody Therapy Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Combination Antibody Therapy Market Size Market Share by Type 2013-2025
Figure Chemotherapy/Antibody Figures
Table Key Players of Chemotherapy/Antibody
Figure Antibody/Antibody Figures
Table Key Players of Antibody/Antibody
Figure Conjugated Antibodies Figures
Table Key Players of Conjugated Antibodies
Figure Bispecific Antibodies Figures
Table Key Players of Bispecific Antibodies
Table Global Combination Antibody Therapy Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Research Institutes Case Studies
Figure Clinics Case Studies
Figure ASCs Case Studies
Figure Combination Antibody Therapy Report Years Considered
Table Global Combination Antibody Therapy Market Size 2013-2025 (Million US$)
Figure Global Combination Antibody Therapy Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Combination Antibody Therapy Market Size by Regions 2013-2025 (Million US$)
Table Global Combination Antibody Therapy Market Size by Regions 2013-2018 (Million US$)
Table Global Combination Antibody Therapy Market Share by Regions 2013-2018
Figure Global Combination Antibody Therapy Market Share by Regions 2013-2018
Figure Global Combination Antibody Therapy Market Share by Regions 2018
Table Market Top Trends
Table Global Combination Antibody Therapy Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Combination Antibody Therapy Market Share by Manufacturers (2013-2018)
Figure Global Combination Antibody Therapy Market Share by Manufacturers in 2018
Table Global Combination Antibody Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Combination Antibody Therapy Product/Solution/Service
Table Date of Enter into Combination Antibody Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table Global Combination Antibody Therapy Market Size Share by Type (2013-2018)
Figure Global Combination Antibody Therapy Market Size Market Share by Type (2013-2018)
Table Global Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table Global Combination Antibody Therapy Market Size Share by Application (2013-2018)
Figure Global Combination Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure Global Combination Antibody Therapy Revenue Market Share by Application in 2017
Figure United States Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table United States Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table United States Key Players Combination Antibody Therapy Market Share (2017-2018)
Table United States Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table United States Combination Antibody Therapy Market Share by Type (2013-2018)
Table United States Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table United States Combination Antibody Therapy Market Share by Application (2013-2018)
Figure Europe Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table Europe Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table Europe Key Players Combination Antibody Therapy Market Share (2017-2018)
Table Europe Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table Europe Combination Antibody Therapy Market Share by Type (2013-2018)
Table Europe Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table Europe Combination Antibody Therapy Market Share by Application (2013-2018)
Figure China Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table China Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table China Key Players Combination Antibody Therapy Market Share (2017-2018)
Table China Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table China Combination Antibody Therapy Market Share by Type (2013-2018)
Table China Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table China Combination Antibody Therapy Market Share by Application (2013-2018)
Figure Japan Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table Japan Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table Japan Key Players Combination Antibody Therapy Market Share (2017-2018)
Table Japan Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table Japan Combination Antibody Therapy Market Share by Type (2013-2018)
Table Japan Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table Japan Combination Antibody Therapy Market Share by Application (2013-2018)
Figure Southeast Asia Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Combination Antibody Therapy Market Share (2017-2018)
Table Southeast Asia Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Combination Antibody Therapy Market Share by Type (2013-2018)
Table Southeast Asia Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Combination Antibody Therapy Market Share by Application (2013-2018)
Figure India Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table India Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table India Key Players Combination Antibody Therapy Market Share (2017-2018)
Table India Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table India Combination Antibody Therapy Market Share by Type (2013-2018)
Table India Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table India Combination Antibody Therapy Market Share by Application (2013-2018)
Figure Central & South America Combination Antibody Therapy Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Combination Antibody Therapy Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Combination Antibody Therapy Market Share (2017-2018)
Table Central & South America Combination Antibody Therapy Market Size by Type (2013-2018) (Million US$)
Table Central & South America Combination Antibody Therapy Market Share by Type (2013-2018)
Table Central & South America Combination Antibody Therapy Market Size by Application (2013-2018) (Million US$)
Table Central & South America Combination Antibody Therapy Market Share by Application (2013-2018)
Table Biogen Company Details
Table Biogen Revenue in Combination Antibody Therapy Business (2013-2018) (Million US$)
Figure Biogen Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Biogen Recent Development
Table Roche Holdings Company Details
Table Roche Holdings Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Roche Holdings Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Roche Holdings Recent Development
Table Seattle Genetics Company Details
Table Seattle Genetics Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Seattle Genetics Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Seattle Genetics Recent Development
Table Amgen Company Details
Table Amgen Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Amgen Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Amgen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Sanofi Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Sanofi Recent Development
Table Celgene Company Details
Table Celgene Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Celgene Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Celgene Recent Development
Table Genmab Company Details
Table Genmab Revenue in Combination Antibody Therapy Business (2013-2018)(Million US$)
Figure Genmab Revenue Growth Rate in Combination Antibody Therapy Business (2013-2018)
Table Genmab Recent Development
Table Global Combination Antibody Therapy Market Size by Regions (Million US$) 2018-2025
Figure Global Combination Antibody Therapy Market Size Share by Regions (2018-2025)
Figure Global Combination Antibody Therapy Market Size Share by Regions in 2025
Figure United States Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Figure Europe Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Figure China Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Figure Japan Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Figure India Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Combination Antibody Therapy Market Size Forecast (2018-2025)(Million USD)
Table Global Combination Antibody Therapy Market Size by Product (2018-2025) (Million US$)
Figure Global Combination Antibody Therapy Market Size by Product (2018-2025)
Figure Global Combination Antibody Therapy Market Size by Product in 2025
Table Global Combination Antibody Therapy Market Size by Application (2018-2025) (Million US$)
Figure Global Combination Antibody Therapy Market Size by Application (2018-2025)
Figure Global Combination Antibody Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
